Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis
2024 · Gastroenterology · 60 citations
https://doi.org/10.1053/j.gastro.2024.05.014
R
Ruiling Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
836
Citations
14
h-index
18
i10-index
Ruiling Chen is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Diseases and Immunity & Hepatitis B Virus Studies. The author has an h-index of 14, co-authored 54 publications.
Papers by this author
worksP4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases
2023 · Hepatology · 41 citations
https://doi.org/10.1097/hep.0000000000000317
A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression
2023 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-023-37213-5
Gut microbiome pattern impacts treatment response in primary biliary cholangitis
2024 · Med · 13 citations
https://doi.org/10.1016/j.medj.2024.08.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat